Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
- A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Neoplasm Malignant
United States, Australia, Canada, Chile, China +14 more
- A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaActive Not Recruiting
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +39 more
Sponsor: UCB Biopharma SRL
Hidradenitis Suppurativa
United States, Australia, Belgium, Bulgaria, Canada +14 more
Sponsor: LEO Pharma
Chronic Hand Eczema
Australia, Belgium, Canada, France, Poland +2 more
Sponsor: Daiichi Sankyo
Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Gastric Cancer
United States, Australia, Belgium, Canada, China +11 more
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
Sponsor: Merck Sharp & Dohme LLC
Hematologic Malignancies · Waldenstroms Macroglobulinaemia · Non-Hodgkins Lymphoma · Chronic Lymphocytic Leukaemia
United States, Argentina, Australia, Brazil, Canada +17 more
Sponsor: Eli Lilly and Company
Peripheral Arterial Disease
United States, Argentina, Australia, Brazil, Canada +11 more
Sponsor: Amgen
Thyroid Eye Disease
United States, France, Germany, Italy, Spain +1 more
- Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous DiseaseActive Not Recruiting
Sponsor: Ensoma
X-Linked Chronic Granulomatous Disease
United States, United Kingdom
Sponsor: AbbVie
Episodic Migraine
United States, Belgium, Canada, Denmark, France +11 more
Sponsor: H. Lundbeck A/S
Episodic Migraine
United States, Argentina, Canada, Italy, Mexico +6 more
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Pacemaker-Induced Cardiomyopathy · Tricuspid Regurgitation · Right Ventricular Dysfunction
United Kingdom
Sponsor: Eli Lilly and Company
Metabolic Dysfunction-Associated Steatotic Liver Disease
United States, Argentina, Australia, Austria, Belgium +29 more
Sponsor: H. Lundbeck A/S
Chronic Migraine in Children
United States, Argentina, Canada, Italy, Mexico +6 more
Sponsor: Pfizer
Pulmonary Arterial Hypertension
United States, Australia, Belgium, China, Czechia +7 more
Sponsor: H. Lundbeck A/S
Cushing's Disease
United States, France, Georgia, Hungary, Italy +4 more
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Argentina, Australia, Belgium, Brazil +10 more
- An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary SarcoidosisActive Not Recruiting
Sponsor: Xentria, Inc.
Pulmonary Sarcoidosis
United States, Czechia, Poland, United Kingdom
Sponsor: AstraZeneca
Prostate Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
- Optical Coherence Tomography in Acute Vessel EvaluationEnrolling By Invitation
Sponsor: Aarhus University Hospital Skejby
Ischemic Heart Disease · Ischemic Coronary Artery Disease · ACS (Acute Coronary Syndrome)
Belgium, Denmark, Estonia, Finland, Italy +6 more
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer · Metastatic Castration-Resistant Prostate Cancer · Metastatic Hormone Sensitive Prostate Cancer
United States, China, France, Germany, Italy +7 more
Sponsor: Novartis Pharmaceuticals
Progressive Metastatic Castrate Resistant Prostate Cancer
United States, Australia, Canada, China, Denmark +9 more
- HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPEnrolling By Invitation
Sponsor: Disc Medicine, Inc
Erythropoietic Protoporphyria
United States, Australia, Belgium, France, Germany +3 more